Latest Dual Listing News

5E Advanced Materials has requested suspension of its shares from ASX trading to enable its removal from the official list, marking a significant shift in its market presence.

Anteris Technologies Global Corp. has initiated an at-the-market equity offering to raise up to US$250 million, aiming to accelerate development of its DurAVR transcatheter heart valve and support general corporate needs.

The Supreme Court of Western Australia has approved the acquisition of Winsome Resources by Li-FT Power, triggering the legal effectiveness of the share and option schemes. Winsome shares will suspend trading on the ASX from 12 May 2026, with key implementation and delisting dates set for later this month.

The Supreme Court of Western Australia has approved the acquisition schemes allowing Li-FT Power to take full ownership of Winsome Resources, with trading suspension on the ASX set for 12 May 2026.

Winsome Resources shareholders and optionholders overwhelmingly backed Li-FT Power’s takeover scheme, clearing a major hurdle before the Supreme Court’s final approval scheduled for 11 May 2026.

Winsome Resources is set for a decisive court hearing on 11 May 2026 to approve Li-FT Power's acquisition scheme, a critical step toward completing the lithium-focused takeover.

Titomic Limited is gearing up for a strategic shift to the US with a planned redomicile in H2 2026, while clinching major contracts across aerospace, defense, and rail sectors and achieving critical certifications that underpin its manufacturing ambitions.

Yugo Metals (ASX:YUG) secured government approval for its Petrovo tenement in Bosnia, while initial drilling at Sinjakovo’s Kovacevac and Erak prospects delivered promising polymetallic results. The company also appointed Petar Tomašević as permanent CEO, positioning itself for further exploration progress.

Brockman Mining Limited continues to develop its Marillana and Ophthalmia iron ore projects through joint ventures, progressing infrastructure plans at Port Hedland while maintaining a modest cash position and strong financing facilities.

Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.

Radiopharm Theranostics has reported encouraging initial results from the Phase 1 HEAT trial of its novel HER2-targeted radiopharmaceutical, 177Lu-RAD202, highlighting tumor uptake and a clean safety profile at the lowest dose with dose escalation approved.

Winsome Resources has advanced its proposed acquisition by Li-FT Power, with shareholder and optionholder meetings scheduled for 5 May 2026 to decide on the scheme of arrangement. The transaction hinges on court approval following a key condition being met.